Matiz SR Capsule contains Mebeverine 200 mg, an antispasmodic agent primarily used to relieve symptoms associated with irritable bowel syndrome (IBS) and other functional gastrointestinal disorders. Mebeverine acts directly on the smooth muscles of the gastrointestinal tract, exerting a spasmolytic effect without affecting normal gut motility. This action helps alleviate abdominal pain, cramps, bloating, and discomfort caused by intestinal muscle spasms. The sustained-release formulation of Matiz SR Capsule ensures a prolonged therapeutic effect, allowing for twice-daily dosing and improved patient compliance. It is generally well tolerated, with a low incidence of adverse effects, which may include mild gastrointestinal disturbances or allergic reactions in rare cases. Matiz SR Capsule is contraindicated in patients with known hypersensitivity to Mebeverine or any of its excipients. Caution is advised in patients with severe hepatic or renal impairment, and its use during pregnancy and lactation should be under medical supervision. Matiz SR Capsule should be used as part of a comprehensive treatment plan, including dietary and lifestyle modifications, to effectively manage symptoms of IBS and related conditions. Always consult a healthcare professional before initiating therapy to ensure appropriate use and dosage.